NCT04544111 2025-10-07PDR001 Combination Therapy for Radioiodine-Refractory Thyroid CancerMemorial Sloan Kettering Cancer CenterPhase 2 Active not recruiting19 enrolled
NCT04462471 2025-09-08Vemurafenib Plus Copanlisib in Radioiodine-Refractory (RAIR) Thyroid CancersMemorial Sloan Kettering Cancer CenterPhase 1 Completed8 enrolled 8 charts